Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing.
Saved in:
| Title: | Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing. |
|---|---|
| Authors: | Dinh P; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Graham JD; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Elder EN; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Kabir M; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia., Doan TB; The Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, 2145, Australia., French J; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Meybodi F; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Hui R; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Wilcken NR; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Harnett PR; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Hsu J; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Stuart KE; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Wang T; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia.; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Ahern V; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Brennan M; Crown Princess Mary Cancer Centre, Western Sydney Local Health District, Westmead, NSW, 2145, Australia.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia., Fox SB; Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia., Dear RF; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, 2010, Australia., Lim E; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, NSW, 2010, Australia.; Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia., White M; Monash Health, Clayton, VIC, 3168, Australia., Mann GB; Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.; Royal Melbourne Hospital, Parkville, VIC, 3050, Australia., Pathmanathan N; Westmead Breast Cancer Institute, Westmead, NSW, 2145, Australia. Nirmala.pathmanathan@health.nsw.gov.au.; Westmead Clinical School, University of Sydney, Westmead, NSW, 2145, Australia. Nirmala.pathmanathan@health.nsw.gov.au.; Douglass Hanly Moir Pathology, Macquarie Park, NSW, 2113, Australia. Nirmala.pathmanathan@health.nsw.gov.au. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Feb; Vol. 191 (3), pp. 501-511. Date of Electronic Publication: 2021 Dec 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-021-06456-5 |
